South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day…
In Conversation
×Middle East & Africa
Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last year and achieved the first Millennium Development Goal…
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for…
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of Denmark, with insulin and anti-infectives produced…
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011,…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as…
